Business

Arcadia's provider customers and life sciences users can leverage Atropos Health's datasets for value-based care and clinical decision-making.

The company's proprietary technology aims to reduce motion sickness in an extended reality environment by stimulating the inner ear's vestibular system.

Sara Shanti, partner at Sheppard Mullin, discusses the intersection of healthcare and technology, how to establish trust and transparency within AI, and questions she receives pertaining to virtual therapy, particularly in mental health.

The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.

Providers are responsible for navigating variable coverage schemes while caring for patients, says Jay Rughani, investment partner at Andreessen Horowitz. AI and LLMs advancements can help fix this trajectory and reduce administrative burnout.  

The funds come two years after the company scored a $1.15 billion investment.

The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.

Dr. Don Rucker, chief strategy officer for 1upHealth, discusses TEFCA going live, ONC's Health IT Certification Program, key takeaways from the final HTI-1 and how ONC's certification rule may burden both providers and vendors.   

Brigid Bondoc, partner and life sciences attorney at Morrison Foerster, discusses government priorities pertaining to federal regulation of AI, where complications may arise, and concerns she has heard related to policy decisions.  

The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis.